This study aims to demonstrate the superiority in clinical performances of a dual artery compression device (Terry-2 band) compared to a standard radial artery-only hemostasis device (HemoSTOP).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
100
Compression device to achieve hemostasis.
IUCPQ - Laval Hospital
Québec, Canada
RECRUITINGRate of RAO after transradial approach (TRA) at hospital discharge
To determine whether the use of a dual artery compression decreases the rate of radial artery occlusion after transradial catheterization.
Time frame: up to 24 hours
Percentage of radial artery patent-hemostasis during hemostasis
To determine the conservation of blood flow through the radial artery during compressive hemostasis
Time frame: throughout intervention, up to 180 minutes
Patient comfort during hemostasis as assessed on a visual scale
To evaluate the level of patient comfort in relation to the device used
Time frame: throughout intervention, up to 30 days
Rates of complications such as repeat bleeding and hematoma (EASY Scale)
To determine the incidence of complications in relation to the device used. Bleeding, spasm and presence of hematomas will be evaluated.
Time frame: throughout intervention, up to 30 days
Nursing involvement in hemostasis management for sensitivity analysis on cost assessment
To determine the overall nursing involvement (time per nurse per patient) in hemostasis monitoring from end of procedure to patient discharge for a cost-benefit evaluation.
Time frame: throughout intervention, up to 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.